Critical Metals Corp. ( CRML) is on a rollercoaster ride. Since rumors surfaced that the U.S. would take an equity stake in ...

Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 ...

Kanagawa University of Human Services-led researchers found short-term BMI reductions after an eight-to-12-week ...

VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...

The KaiNETIC global Phase 3 clinical program includes three global, double-blind, randomized, placebo-controlled Phase 3 trials (KaiNETIC-1, KaiNETIC-2, and KaiNETIC-3) to evaluate weekly ribupatide ...

The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...

Elevra Lithium sits between exploration and mature production, offering operating leverage. Read why I rate ELVR stock a Hold ...

Helium–Neon Mixed Refrigerant System to Support Advanced Cryogenic Research at Kwinana Energy Transformation Hub This ...

Schaeffler noted that several systems reflected the integration of software assets gained through its acquisition of Vitesco ...

Industry expert Michael Sura does the detective work and comes up with a hypothesis on how an Indian PhD’s “Solid-State ...

(NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce the deployment of Draganfly drones ...

AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin ...